U.S., July 3 -- ClinicalTrials.gov registry received information related to the study (NCT07047235) titled 'Substrate Remodelling and Targeted Ablation in AF' on June 24.
Brief Summary: Atrial fibrillation (AF) is the most common heart rhythm disorder, affecting millions worldwide and causing symptoms such as palpitations, fatigue and breathlessness. It also increases the risk of stroke and heart failure, so effective treatment is essential.
A treatment for AF involves catheter ablation, a minimally invasive procedure where problematic areas of the heart are targeted using controlled heart energy. This is done by passing wires called catheters, through blood vessels at the top of the leg all the way to the heart. However, this isn't effec...